12 research outputs found
Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures
Neonatal seizures can be refractory to conventional anticonvulsants, and this may in part be due to a developmental increase in expression of the neuronal Na+-K+-2 Cl− cotransporter, NKCC1, and consequent paradoxical excitatory actions of GABAA receptors in the perinatal period. The most common cause of neonatal seizures is hypoxic encephalopathy, and here we show in an established model of neonatal hypoxia-induced seizures that the NKCC1 inhibitor, bumetanide, in combination with phenobarbital is significantly more effective than phenobarbital alone. A sensitive mass spectrometry assay revealed that bumetanide concentrations in serum and brain were dose-dependent, and the expression of NKCC1 protein transiently increased in cortex and hippocampus after hypoxic seizures. Importantly, the low doses of phenobarbital and bumetanide used in the study did not increase constitutive apoptosis, alone or in combination. Perforated patch clamp recordings from ex vivo hippocampal slices removed following seizures revealed that phenobarbital and bumetanide largely reversed seizure-induced changes in EGABA. Taken together, these data provide preclinical support for clinical trials of bumetanide in human neonates at risk for hypoxic encephalopathy and seizures
Dorsally located corneal dermoid in a cat
Case summary A 2-month-old, male kitten was presented for evaluation of unilateral blepharospasm and epiphora involving the right eye. Ocular examination revealed conjunctivitis, a superficial corneal ulcer, reflex anterior uveitis and a haired mass within the dorsal cornea of the right eye. The mass was subsequently removed surgically via a lamellar keratectomy. Histologic evaluation of the mass via light microscopy revealed it to be comprised of normal-haired skin with mild inflammation. One week after surgical removal and medical management of the corneal ulcer, all ocular clinical signs had resolved with minimal corneal scarring. On re-examination 6 months following surgical excision of the mass, the kitten was noted to be comfortable with no significant corneal scarring. Relevance and novel information To our knowledge, this is the first case report of a dorsally located corneal dermoid in a cat
Correction: Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures.
Lassa Virus Targeting of Anterior Uvea and Endothelium of Cornea and Conjunctiva in Eye of Guinea Pig Model
Lassa virus (LASV), a hemorrhagic fever virus endemic to West Africa, causes conjunctivitis in patients with acute disease. To examine ocular manifestations of LASV, we histologically examined eyes from infected guinea pigs. In fatal disease, LASV immunostaining was most prominent in the anterior uvea, especially in the filtration angle, ciliary body, and iris and in and around vessels in the bulbar conjunctiva and peripheral cornea, where it co-localized with an endothelial marker (platelet endothelial cell adhesion molecule). Antigen was primarily associated with infiltration of T-lymphocytes around vessels in the anterior uvea and with new vessel formation at the peripheral cornea. In animals that exhibited clinical signs but survived infection, eyes had little to no inflammation and no LASV immunostaining 6 weeks after infection. Overall, in this model, LASV antigen was restricted to the anterior uvea and was associated with mild chronic inflammation in animals with severe disease but was not detected in survivors
Correction: Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures
EEG recording schedule and representative electrographic seizure.
<p>(A) After SWE implantation, continuous video-EEG was recorded from each rat for a total of 90 min. Recordings began 45 min before the start of hypoxia and ran an additional 30 min after the termination of hypoxia. Phenobarbital (pheno) was injected 30 min before hypoxia, and was followed by bumetanide (BMX) injection 15 min later. Epochs totaling 5 min were selected from the recording during hypoxia for EEG power analysis. Random selections from the baseline recording were used as controls. (B) Representative baseline EEG recording from a P10 rat prior to treatment and exposure to graded global hypoxia. (C) Typical electrographic seizure recorded from one hemisphere (other hemisphere not shown) in a P10 rat during the course of hypoxia. All electrographic seizures were accompanied by behavioral automatisms. Arrow indicates seizure onset. Insets of the EEG trace in an expanded time scale show seizure initiation, followed by a progressive buildup in spikes of increasing frequency and amplitude, regular tonic spike wave discharges, and post-ictal slowing following seizure termination.</p
Phenobarbital and bumetanide, singly or in combination, did not increase constitutive cell death in P10 rat pups.
<p>Representative photomicrographs and magnified insets of TUNEL staining on 16 µm coronal sections of parietal cortex 48 h after treatment with (A) MK801 (positive control), (B) vehicle (DMSO in 0.9% saline) (n = 10), (C) phenobarbital (n = 11), (D) high dose bumetanide (n = 11), or (E) combined phenobarbital and high dose bumetanide (n = 8). Sections were lightly counterstained with methyl green. Pictures were taken at low power to maximize scoring, and magnified insets show detail. Other regions examined were amygdala, caudate-putamen, hippocampus, and thalamus. Apoptotic cells can be seen as dark pyknotic nuclei (arrows denote examples). No treatment significantly increased constitutive apoptosis compared to vehicle when analyzed within each region or in the total area (p = 0.129). A P7 rat pup treated with MK801 served as a positive control, and showed numerous apoptotic neurons clustered in layer II but also in other cortical layers. Scale bar = 200 µm (inset scale bar = 35 µm).</p
Seizure number, cumulative duration, and EEG power attenuation in rats treated with phenobarbital and bumetanide.
<p>The number of hypoxia-induced seizures (A), and cumulative seizure duration (B) were plotted for each treatment group. Vehicle-treated rats (n = 38) averaged 11.8±0.7 seizures, with an average cumulative seizure duration of 229±16.3 s. Treatment with phenobarbital (pheno) reduced seizure incidence by approximately 50% (n = 33, 6.8±1.0, 122±20.8 s), but did not completely attenuate activity. The combination of phenobarbital and 0.15 mg/kg bumetanide (pheno +0.15 mg/kg BMX) reduced seizure incidence by approximately 75% compared to vehicles (n = 35, 3.8±0.9, 61.3±16.1 s), and was more effective than phenobarbital alone. The higher dose (pheno +0.3 mg/kg BMX) was even more effective, decreasing seizure activity by ∼85% from vehicles (n = 25, 1.6±0.6, 38.5±17.0 s), and ∼75% from phenobarbital. (C) FFT analysis revealed increased spectral power between 4–12 Hz during seizures (vehicle). The average summed power between 4–12 Hz was plotted for each treatment group. Treatment with phenobarbital (n = 5, 56.8±8.1 µV), bumetanide (low dose: n = 3, 45.84±7.4 µV; high dose: n = 5, 47.1±5.5 µV), and the combination of phenobarbital and low dose bumetanide (n = 3, 30.0±9.4 µV) had little effect on summed power at these frequencies. However, in rats treated with the high dose combination (n = 4, 24.6±3.0 µV) summed power was reduced to levels similar to pre-hypoxia baseline EEG recordings (control). Mean ± SEM. Error bars indicate SEM. *<i>p</i><0.05, **<i>p</i><0.01, ***<i>p</i><0.001.</p
The combination of phenobarbital and bumetanide alter E<sub>GABA</sub> in CA1 neurons from slices removed at 24 hr post-hypoxic seizures.
<p>GABA-evoked currents were measured from hippocampal slices taken from rats (n = 6) 24 hr after hypoxia-induced seizures. (A) Typical examples of GABA-evoked currents in CA1 neurons at various holding potentials after application of phenobarbital (PB, 100 mM), and phenobarbital in combination with bumetanide (PB+BM). Treatment effects were compared to normal conditions (HS) prior to drug administration. (B) Current–voltage curves for the recordings shown in A. The data points were fitted with a straight line. (C) Summary of the reversal potential of GABA-evoked currents under different recording conditions: control (HS, −58.61±1.28 mV), phenobarbital only (PB, −58.46±1.58 mV), and phenobarbital in combination with bumetanide (PB+BM, −64.53±2.30 mV). Error bars indicate SEM. *<i>p</i><0.05.</p
Seizure-induced alterations in NKCC1 and KCC2 protein levels.
<p>Using Western Blot, NKCC1 and KCC2 protein levels were assessed in cortical and hippocampal tissue obtained from P10 rats at 1, 12, 24, 48, and 168 hr after hypoxia-induced seizures (HS), and compared to age-matched littermate controls. Optical densities for NKCC1 and KCC2 were normalized to actin, averaged for each time point, and then the average expression in hypoxic animals was normalized to that in control animals. NKCC1 (A) and KCC2 (B) expression was plotted as a percent of control (dotted line). NKCC1 increased transiently at 24 hr post-HS (n = 8, 138±10.5% control, <i>p</i> = 0.005) in cortex, but showed no significant change in hippocampus. KCC2 expression increased early at 1 hr post-HS (n = 4, 140±9.6% control, <i>p</i> = 0.004) in hippocampus, with a later cortical increase 24 hr post-HS (n = 8, 81±6.7% control, <i>p</i> = 0.025). The normalized ratio of NKCC1 to KCC2 (C) was then calculated as a measure of changes in the relative expression of NKCC1 and KCC2 from normal expression patterns. In the cortex, the ratio of NKCC1 to KCC2 initially decreased 1 hr after seizures (n = 7, 0.66±0.09 fold, p = 0.003), and then increased at 12 and 24 hr (12 hr: n = 7, 1.71±0.27 fold, <i>p</i> = 0.046; 24 hr: n = 8, 1.83±0.26 fold, <i>p</i> = 0.008), as compared to controls. In the hippocampus, NKCC1/KCC2 was significantly higher at 12 hr (n = 8, 1.39±0.09 fold, p = 0.016), as compared to controls. (D) Representative western blot images for NKCC1, KCC2, and actin protein levels in cortex (top) and hippocampus (bottom). C = control; HS = hypoxic seizures. Mean ± SEM. Error bars indicate SEM.*<i>p</i><0.05, **<i>p</i><0.01.</p